Genertec Universal Medical Group Files Director List with HKEX

Reuters
2025/12/18
Genertec Universal Medical Group Files Director List with HKEX

Genertec Universal Medical Group Co. Ltd. has filed its latest list of directors and their roles with the Hong Kong Stock Exchange. The Board is led by Executive Director and Chairman Mr. Chen Shisu, alongside CEO Mr. Wang Wenbing and Ms. Wang Lin. Non-executive Directors include Mr. Tong Chaoyin, Mr. Lin Chunhai, Mr. Huang Youjie, and Mr. Ma Wanming. The Independent Non-executive Directors are Mr. Li Yinquan, Mr. Chow Siu Lui, Mr. Xu Zhiming, and Mr. Chan Hiu Fung Nicholas. The company has established five committees. The Audit Committee is chaired by Mr. Li Yinquan, with Mr. Chow Siu Lui and Mr. Tong Chaoyin as members. The Remuneration Committee is chaired by Mr. Chow Siu Lui, with Mr. Lin Chunhai, Mr. Huang Youjie, Mr. Li Yinquan, and Mr. Xu Zhiming serving as members. The Nomination Committee is chaired by Mr. Chen Shisu, joined by Ms. Wang Lin, Mr. Li Yinquan, Mr. Chow Siu Lui, and Mr. Chan Hiu Fung Nicholas. Mr. Chen Shisu also chairs the Strategy and ESG Committee, with Mr. Huang Youjie and Mr. Ma Wanming as members. The Risk Control Committee is chaired by Mr. Ma Wanming, with Mr. Wang Wenbing and Mr. Tong Chaoyin as members.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Genertec Universal Medical Group Co. Ltd. published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20251218-11959822), on December 18, 2025, and is solely responsible for the information contained therein.

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10